These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1229 related items for PubMed ID: 16083542

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
    Rösler M.
    Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS.
    J Clin Psychiatry; 2003 Jun; 64 Suppl 9():11-7. PubMed ID: 12934969
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S, Hill J, Fillit H.
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Cholinesterase inhibitors in the treatment of dementia.
    Ellis JM.
    J Am Osteopath Assoc; 2005 Mar; 105(3):145-58. PubMed ID: 15863734
    [Abstract] [Full Text] [Related]

  • 54. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N.
    Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years.
    Small GW, Kaufer D, Mendiondo MS, Quarg P, Spiegel R.
    Int J Clin Pract; 2005 Apr; 59(4):473-7. PubMed ID: 15853867
    [Abstract] [Full Text] [Related]

  • 59. Donepezil: tolerability and safety in Alzheimer's disease.
    Pratt RD, Perdomo CA, Surick IW, Ieni JR.
    Int J Clin Pract; 2002 Nov; 56(9):710-7. PubMed ID: 12469988
    [Abstract] [Full Text] [Related]

  • 60. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.
    J Neurol Sci; 2012 Nov 15; 322(1-2):96-101. PubMed ID: 22959283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.